← Open Payments lookup

JENNIFER BROWN: Open Payments

NPI 1275882789 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,168 in 71 payments from 16 companies in 2025. Trend: 2023 $1,379 · 2024 $4,135 · 2025 $2,168

Food & beverage: $2,168
CompanyPaymentsAmount
ABBVIE INC.16$433
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$418
E.R. Squibb & Sons, L.L.C.13$342
Axsome Therapeutics, Inc.5$194
Janssen Pharmaceuticals, Inc3$181
Supernus Pharmaceuticals, Inc.1$122
Vanda Pharmaceuticals Inc.4$112
Neurocrine BioSciences, Inc.4$95
Lundbeck LLC3$60
Teva Pharmaceuticals USA, Inc.2$42

Products named: VRAYLAR, CAPLYTA, COBENFY, Auvelity, SPRAVATO, Qelbree, FANAPT, REXULTI.

Industry payments across TX — which companies pay providers there.